Your Article Summary
See Latest ArticlesMedImmune Funds Study to Help Gain Insights Into Full Burden of RSV Disease Among Premature Infants
Medimmune, 06/30/09
MedImmune continues to advance its commitment to pediatric research with announcement of the first observational prospective study designed to assess the burden of respiratory syncytial virus among preterm infants 32-to-35 weeks gestational age in outpatient settings during their first year of life.
Today in Major Studies...keeping you current
Receive free subspecialty "5-minute updates" via email
A prospective phase II study of cetuximab in combination with XELOX (capecitabine and oxaliplatin) in patients with metastatic and/or recurrent advanced gastric cancer
Investigational New Drugs, 12/18/09
Evaluation of Treatment Satisfaction in Children with Allergic Disease Treated with an Antihistamine: An International, Non-Interventional, Retrospective Study
Clinical Drug Investigation, 12/11/09
Sanofi Pasteur Global Dengue Vaccine Clinical Program Expanded in Latin America
Sanofi-aventis, 12/10/09